Showing 131 - 140 of 170,278
obligations compared to European peers. First, we provide an account of Sweden's strategy and the health outcomes. Second, drawing …
Persistent link: https://www.econbiz.de/10013315101
), have been approved by the World Health Organization (WHO) for inclusion in its Emergency Use Listing (EUL). The analysis is …
Persistent link: https://www.econbiz.de/10012818093
sensitivity of the vaccinated proportion, providing causality and evidence that expanding and expediting COVID-19 vaccination can …
Persistent link: https://www.econbiz.de/10012650179
COVID-19 has led to large numbers of deaths, harms, and financial costs. Without an effective vaccine, those will continue. The pressure to find a vaccine is high; and that pressure creates a risk that the safeguards in place to assure that vaccines are safe and effective will be ignored. The...
Persistent link: https://www.econbiz.de/10013248453
public health.Unless WTO members reach a consensus, the multilateral trading system may be further complicated by a delay …
Persistent link: https://www.econbiz.de/10013248992
in granting broad worldwide access to vaccination. The accumulated delays in providing effective Covid-19 vaccine …
Persistent link: https://www.econbiz.de/10013254230
The economic and health recovery of countries in the Asia-Pacific region from the pandemic is hinged on the rapid and … an issue, health system challenges, particularly in terms of financing, service delivery, human resources, regulatory … paper revolve around the importance of strengthening the health system to enable the equitable allocation and distribution …
Persistent link: https://www.econbiz.de/10013449425
Quickly developed therapeutic, prophylactic, and vaccine treatments will be essential to defeat the COVID-19 pandemic. Standard regulatory and development protocols typically yield drug development in 6 to 11 years. However, experimental vaccines and prophylactics against COVID-19 are in...
Persistent link: https://www.econbiz.de/10014100167
Objectives: This note provides an assessment of COVID-19 acceleration among groups with different vaccine status in France.Methods: We assess viral acceleration using a novel indicator introduced in Baunez et al. (2021). The acceleration index relates the percentage change of tests that have...
Persistent link: https://www.econbiz.de/10013324430
Operation Warp Speed (OWS) was a U.S. government-led program to accelerate the development, production, and administration of COVID-19 vaccines. The program cut the typical ten-year timeline needed to develop a new vaccine down to ten months and began vaccinating vulnerable populations within a...
Persistent link: https://www.econbiz.de/10015056157